ErbB4 Gene Polymorphism Is Associated With the Risk and Prognosis of Congestive Heart Failure in a Northern Han Chinese Population

Journal of Cardiac Failure

Volumn 22, Issue 9, 2016, Pages 700-709

  Wang, Yunhong ^a   Zhang, Yuhui ^a   An, Tao ^a   Zhang, Rongcheng ^a   Zhao, Xuemei ^a   Liu, Nini ^a   Yin, Shijie ^a   Gan, Tianyi ^a   Liang, Tuo ^a   Huang, Yan ^a   Zhou, Qiong ^a   Zhang, Jian ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

ErbB4; heart failure; polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; ERBB4 PROTEIN, HUMAN; MICRORNA;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HEART DEATH; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BINDING SITE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HEART FAILURE; INCIDENCE; MIDDLE AGED; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAIWAN;

AGED; ALLELES; BINDING SITES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, ERBB-4; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAIWAN;

EID: 84960539674     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.01.013     Document Type: Article

References (23)

1. 1 Braunwald, E., Heart failure. JACC Heart Fail 1 (2013), 1–20.
2. 2 Lemmens, K., Doggen, K., de Keulenaer, G.W., Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 116 (2007), 954–960.
3. 3 Galindo, C.L., Ryzhov, S., Sawyer, D.B., Neuregulin as a heart failure therapy and mediator of reverse remodeling. Curr Heart Fail Rep 11 (2014), 40–49.
4. 4 Lenneman, C.G., Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure. Curr Heart Fail Rep 11 (2014), 134–138.
5. 5 Mendes-Ferreira, P., De Keulenaer, G.W., Leite-Moreira, A.F., Bras-Silva, C., Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug Discov Today 18 (2013), 836–842.
6. 6 McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14 (2012), 803–869.
7. 7 Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr, Drazner, M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–239.
8. 8 Glickman, M.E., Rao, S.R., Schultz, M.R., False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 67 (2014), 850–857.
9. 9 Xu, Z., Taylor, J.A., SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37 (2009), W600–5 Web Server issue.
10. 10 Gao, R., Zhang, J., Cheng, L., Wu, X., Dong, W., Yang, X., et al. A phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol 55 (2010), 1907–1914.
11. 11 Liu, X., Gu, X., Li, Z., Li, X., Li, H., Chang, J., et al. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48 (2006), 1438–1447.
12. 12 Bersell, K., Arab, S., Haring, B., Kuhn, B., Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138 (2009), 257–270.
13. 13 Fukazawa, R., Miller, T.A., Kuramochi, Y., Frantz, S., Kim, Y.D., Marchionni, M.A., et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 35 (2003), 1473–1479.
14. 14 Okoshi, K., Nakayama, M., Yan, X., Okoshi, M.P., Schuldt, A.J., Marchionni, M.A., et al. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion. Circulation 110 (2004), 713–717.
15. 15 Matsukawa, R., Hirooka, Y., Ito, K., Honda, N., Sunagawa, K., Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure. J Hypertens 32 (2014), 817–825.
16. 16 Pentassuglia, L., Sawyer, D.B., The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 315 (2009), 627–637.
17. 17 Negro, A., Brar, B.K., Lee, K.F., Essential roles of Her2/ErbB2 in cardiac development and function. Recent Prog Horm Res 59 (2004), 1–12.
18. 18 Liu, F.F., Stone, J.R., Schuldt, A.J., Okoshi, K., Okoshi, M.P., Nakayama, M., et al. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 289 (2005), H660–6.
19. 19 Jabbour, A., Hayward, C.S., Keogh, A.M., Kotlyar, E., McCrohon, J.A., England, J.F., et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 13 (2011), 83–92.
20. 20 Mei, L., Nave, K.-A., Neuregulin-ErbB signaling in the nervous system and neuropsychiatric diseases. Neuron 83 (2014), 27–49.
21. 21 Huertas-Vazquez, A., Teodorescu, C., Reinier, K., Uy-Evanado, A., Chugh, H., Jerger, K., et al. A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm 10 (2013), 994–998.
22. 22 Wadugu, B., Kuhn, B., The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation. Am J Physiol Heart Circ Physiol 302 (2012), H2139–47.
23. 23 Icli, B., Bharti, A., Pentassuglia, L., Peng, X., Sawyer, D.B., ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response. Biochem Biophys Res Commun 418 (2012), 116–121.